US stocks turn lower ahead of a busy earnings week


In this Nov. 5, 2020 file photo, a sign for Wall Street is carved in the side of a building, in New York. Technology stocks were off to a good start on Wall Street, but other parts of the markets weren't as strong, leaving major indexes mixed in the early going. The S&P 500 was up 0.3% in the first few minutes of trading Monday, Jan. 25, 2021, and the tech-heavy Nasdaq climbed 1.4%. (AP Photo/Mark Lennihan, File)

NEW YORK (AP) — Stocks turned lower in late-morning trading on Monday, as investors looked ahead to this week's deluge of company earnings and remained concerned about the economic damage from a rise in coronavirus cases in some countries.

The S&P 500 was down 0.6% as of 11:15 a.m. Eastern after being up 0.4% earlier. The Nasdaq composite was down 0.4% and the Dow Jones Industrial Average was down 335 points, mostly due to financial companies like Goldman Sachs and American Express.

Several big companies will report their results this week, including technology titan Apple. The iPhone maker will report its results on Wednesday after the closing bell. Others reporting this week include American Express, Johnson & Johnson, 3M and AT&T.

Investors are weighing evidence of the economic damage of current coronavirus restrictions against hopes that once the pandemic comes under some control, economies will bounce back.

“Vaccine breakthroughs make it likely that life will become more functional again at some point in 2021, resulting in higher GDP growth and more robust corporate earnings,” Stephen Innes, chief global markets strategist at Axi, said in a report.

However, increasing global infections and new variants of the virus, along with "tightening social distancing restrictions and delays in vaccine rollouts in some places, all increase the near-term growth risks,” he said.

Markets have been mostly rallying recently on hopes that COVID-19 vaccines will lead to a powerful economic recovery later this year as daily life gets closer to normal. Hopes are also high that Washington will deliver another dose of stimulus for the economy now that the White House and both houses of Congress are under single control of the Democrats.

President Joe Biden has proposed a $1.9 trillion plan to send $1,400 to most Americans and deliver other support for the economy. But his party holds only the slimmest possible majority in the Senate, raising doubts about how much can be approved. Several Republicans have already voiced opposition to parts of the plan.


The coronavirus pandemic is also worsening and doing more damage to the economy by the day. A UN agency said Monday that four times as many jobs were lost last year as in 2009, during the global financial crisis.

GameStop, the video-game retailer that’s struggling to return to profitability, surged another 113% as an army of smaller-pocketed, optimistic investors bear down on big institutional investors who think the stock has to fall. The stock continues to be halted for its sudden surges.

GameStop’s stock neared $160 in the morning, after sitting below $18 just a few weeks ago. It took off earlier this month after naming three new directors to its board to help speed its turnaround, including the founder of online pet-supply retailer Chewy. Some high-profile investors have been saying its stock price was too high and placed bets to profit from an eventual drop by “shorting” it, or borrowing shares of GameStop and selling them.

But a cavalcade of smaller investors has been exhorting each other on the internet to keep the momentum rolling higher for the stock. That’s pushing short sellers to get out of their bets, done by buying the stock, which is helping accelerate its momentum to the moon.

All the while, GameStop’s stock keeps rising even though it lost nearly $296 million in the nine months through Oct. 31.

Should you invest $1,000 in Johnson & Johnson right now?

Before you consider Johnson & Johnson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson & Johnson wasn't on the list.

While Johnson & Johnson currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Johnson & Johnson (JNJ)
4.8922 of 5 stars
$149.12+0.8%3.19%9.30Hold$175.86
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

JNJ shares hit a low, trading near $145 at under 14X earnings. With a high dividend yield, it's poised for a rebound.

Search Headlines: